Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Sophie Vanherrewege
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
5
Results
2024
In-depth analysis of the HIV reservoir confirms effectiveness and safety of dolutegravir/lamivudine in a phase 4 randomized controlled switch trial (RUMBA)
Marie-Angélique De Scheerder
Sophie Degroote
Mareva Delporte
Maja Kiselinova
Wim Trypsteen
Lara Vincke
Evelien De Smet
Bram Van Den Eeckhout
Loic Schrooyen
Maxime Verschoore
et al.
A1
Journal Article
in
JOURNAL OF INFECTIOUS DISEASES
2024
Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study
Jozefien De Clercq
Marie-Angélique De Scheerder
Sophie Vanherrewege
Els Caluwe
Nathalie Moreels
Danny Delooze
Annemieke Dhondt
Marc Coppens
Stefaan J. Vandecasteele
Sabine D. Allard
et al.
A1
Journal Article
in
JOURNAL OF VIRUS ERADICATION
2024
2022
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting : a randomized placebo-controlled phase II trial
Els Tobback
Sophie Degroote
Sabine Buysse
Liesbeth Delesie
Lucas Van Dooren
Sophie Vanherrewege
Cyril Barbezange
Veronik Hutse
Marta Romano
Isabelle Thomas
et al.
A1
Journal Article
in
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2022
Impact of switch towards 3TC/dolutegravir on the intact and total viral reservoir in the Rumba study
Evy Blomme
Wim Trypsteen
Mareva Delporte
C. Muccini
E. De Smet
Sophie Degroote
Els Tobback
Sophie Vanherrewege
E. Caluwe
Marie-Angélique De Scheerder
et al.
C3
Conference
2022
Understanding changes in metabolic parameters switching to 2DR or 3DR integrase strand inhibitors (InSTIs)
Sophie Degroote
Sophie Vanherrewege
Els Tobback
E. Caluwe
Lara Vincke
Evy Blomme
Linos Vandekerckhove
Marie-Angélique De Scheerder
C3
Conference
2022